Skip to content

Formula for Children With Cow's Milk Allergy

A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02317952
Enrollment
90
Registered
2014-12-17
Start date
2014-05-31
Completion date
2016-12-31
Last updated
2017-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Milk Allergy

Brief summary

The purpose of this study is to determine if a new extensively hydrolyzed formula can be consumed by children with Cow's Milk Allergy.

Interventions

OTHERActive Comparator Formula

Sponsors

Perrigo Nutritionals
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
No minimum to 13 Years
Healthy volunteers
No

Inclusion criteria

* Good health * Parent/guardian must be willing to provide informed consent * Parent/guardian agrees to feed study formula provided * Confirmation of Cow's Milk Allergy

Exclusion criteria

* No clinically significant abnormal findings on medical history, laboratory results, and physical exam. * No medications that may interfere with or impact evaluation of the study assessments * Allergy to extensively hydrolyzed casein formula * Tolerance of 200 ml of cow's milk, cow's milk-based formula or food products containing intact cow's milk protein within 2 weeks of the Screening Visit * Participation in another clinical trial within 30 days of screening where they are are receiving an active intervention

Design outcomes

Primary

MeasureTime frame
Incidence of Allergic Reaction2 weeks

Secondary

MeasureTime frameDescription
Growth16 weeksAnthropometric measurements of weight in all enrolled subjects.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026